Vijaya Diagnostics Q3 Revenue Soars 21%, Margins Expand Sharply

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorSimar Singh|Published at:
Vijaya Diagnostics Q3 Revenue Soars 21%, Margins Expand Sharply
Overview

Vijaya Diagnostic Centre posted robust Q3 FY26 results, with revenue climbing 21.4% YoY to ₹205.21 Cr and EBITDA up 28.2%. EBITDA margins improved by 221 bps to 41.9%. While PAT saw a marginal 0.2% dip QoQ to ₹43.18 Cr, it grew 22.3% YoY. The company highlighted strong volume growth and strategic network expansion, including successful hub launches in East India and tier-2/3 cities. Management eyes further expansion and technology investment.

📉 The Financial Deep Dive

Vijaya Diagnostic Centre Limited has reported a strong performance in its third quarter (Q3) for FY26, showcasing significant year-on-year (YoY) growth while navigating quarter-on-quarter (QoQ) dynamics.

The Numbers:

For Q3 FY26, the company posted Revenue from Operations of ₹205.21 Cr, a substantial 21.4% increase compared to ₹168.98 Cr in Q3 FY25. EBITDA surged by 28.2% YoY to ₹86.05 Cr. Crucially, EBITDA margins saw a healthy expansion of 221 basis points (bps), reaching 41.9% from 39.7% in the prior year. Profit After Tax (PAT) also grew robustly by 22.3% YoY to ₹43.18 Cr, with PAT margins improving by 15 bps to 21.0%. Earnings Per Share (EPS) Basic rose to ₹4.2, up 22.2% YoY.

On a quarter-on-quarter basis, revenue grew by a modest 1.8% to ₹205.21 Cr. EBITDA saw a 5.2% increase QoQ to ₹86.05 Cr, with margins expanding by 134 bps to 41.9%. However, PAT witnessed a slight dip of 0.2% QoQ to ₹43.18 Cr, and PAT margins decreased by 43 bps to 21.0%. EPS remained flat at ₹4.2.

For the nine-month period (9M) of FY26, revenue grew 17.1% YoY to ₹594.83 Cr, EBITDA increased 18.1% YoY to ₹241.41 Cr, and PAT rose 14.8% YoY to ₹125.05 Cr.

The Quality:

The YoY performance highlights operational efficiency and strong demand, evidenced by margin expansion across EBITDA and PAT. The improvement in EBITDA margin by 221 bps YoY is a key indicator of profitable growth. While the QoQ PAT flatness warrants monitoring, the overall trend remains positive, supported by volume growth of approximately 15% as stated by management.

Cash flow from operating activities for FY25 stood at ₹2,245 Mn, showing healthy conversion from net profit. The company reported surplus cash of ₹2,067 Mn as of March 2025, alongside substantial lease liabilities of ₹2,964 Mn, indicating a primarily asset-light expansion model with financed leases.

The Grill:

Management commentary focused on the success of strategic initiatives, particularly the hub-and-spoke model. The stabilization of newly launched hubs and the ahead-of-schedule break-even achieved by two hubs in West Bengal demonstrate effective execution. No significant concerns or direct questioning points were highlighted in the provided text regarding guidance or cost pressures.

Risks & Outlook:

The forward view emphasizes continued focus on stabilizing new hubs, commissioning more spokes, and investing in technology for customer experience. Expansion plans are slated for H2 FY26 and H1 FY27 across various geographies. Key risks include the execution of these expansion plans, potential increased competition in emerging markets, and managing operational costs as the network grows. Investors will be keen to watch the profitability trajectory of new centers and the sustained margin performance.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.